Collecting Tissue Samples for Future Research From Women Undergoing Surgery for Breast Cancer
NCT ID: NCT00898131
Last Updated: 2025-10-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
10000 participants
OBSERVATIONAL
2001-08-31
2026-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
PURPOSE: This phase I study is collecting tissue samples for future research from women undergoing surgery for breast cancer.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
NCT00899301
Studying Tissue Samples From Women With Breast Cancer Who Were Treated on Clinical Trial NCCTG-N9831
NCT00898898
Collecting Information From Patients Enrolled in the Breast Specialized Program of Research Excellence
NCT01004562
Studying Normal Breast Tissue and Cancer Risk
NCT00341692
Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer
NCT00001496
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary
* Collect breast tissue for future research from women undergoing surgery for breast cancer.
Secondary
* Create microarrays by tumor type for internal use by Specialized Program of Research Excellence.
OUTLINE: Tumor tissue is collected and analyzed to create microarrays by tumor type for future research studies.
PROJECTED ACCRUAL: A total of 1,250 patients will be accrued for this study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Undergoing surgery for breast cancer
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Northwestern University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Piotr Kulesza, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Northwestern University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Clinical Trials Office - Robert H. Lurie Comprehensive Cancer
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NU-NCI-01X1
Identifier Type: -
Identifier Source: secondary_id
NCI-01X1
Identifier Type: -
Identifier Source: secondary_id
STU00023488
Identifier Type: OTHER
Identifier Source: secondary_id
NCI 01X1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.